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DEVELOPMENT OF A PROTO-TYPOLOGY OF OPIATE OVERDOSE ONSET 
 
ABSTRACT 
 
Background and aims: The time available to act is a crucial factor affecting the likely 
success of interventions to manage opiate overdose. We analyse opiate users’ accounts of 
non-fatal overdose incidents to i. construct a proto-typology of non-fatal opiate overdose 
onset and ii. assess the implications for overdose management and prevention of fatalities.  
 
Methods: Re-analysis of a subset of data from a large qualitative study of non-fatal opiate 
overdose conducted 1997-1999. Data were generated from semi-structured interviews 
undertaken with opiate users who had experienced a non-fatal overdose in the previous 24 
hours. Forty-four participants (30 men; 14 women; 16-47 years) provided sufficient 
information for in-depth analysis. Data relating to ‘memory of the moment of overdose’, 
‘time to loss of consciousness’, and ‘subjective description of the overdose experience’ were 
scrutinised using Iterative Categorisation. 
 
Findings: Four types of overdose onset were identified. Type A “Amnesic” (n=8): 
characterised by no memory, rapid loss of consciousness, and no description of the overdose 
experience. Type B “Conscious” (n=17): characterised by some memory, sustained 
consciousness, and a description of the overdose in terms of feeling unwell and symptomatic. 
Type C “Instant” (n=14): characterised by some memory, immediate loss of consciousness, 
and no description of the overdose experience. Type D “Enjoyable” (n=5): characterised by 
some memory, rapid loss of consciousness, and a description of the overdose experience as 
pleasant or positive. 
 
Conclusions: The identification of different types of overdose onset highlights the 
complexity of overdose events, the need for a range of interventions, and the challenges faced 
in managing incidents and preventing fatalities. Opiate overdose victims who retain 
consciousness for a sustained period and recognize the negative signs and symptoms of 
overdosing could summon help or self-administer naloxone, thus indicating that opiate 
overdose training should incorporate self-management strategies.  
 
KEY WORDS: overdose, opiates, naloxone, overdose management, qualitative study   
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DEVELOPMENT OF A PROTO-TYPOLOGY OF OPIATE OVERDOSE ONSET 
 
 
INTRODUCTION 
 
The World Health Organisation estimates that 69,000 people die from opiate overdose 
annually [1]. Further, in some countries, there are overlapping epidemics of opioid overdose 
deaths. In the US, for example, there has been a greater than fourfold increase in prescription 
opioid deaths since 1999, including more than sixteen thousand in 2010 alone [2]. This 
coincides with a more recent but sharper epidemic of heroin overdose deaths from 2007 
onwards, to levels now comparable to prescription opioid deaths [3]. In the UK, heroin 
overdose deaths also remain persistently high and have recently risen again (by 64% between 
2012 and 2014) [4].  
 
Analyses of drug-related deaths consistently find that the illicit drug most usually involved is 
heroin [4-6]. Heroin overdoses and their circumstances have now been widely studied and a 
recent review has identified a number of recurrent themes: namely, most overdoses are 
unintentional (rather than suicides or parasuicides), overdoses occur primarily amongst 
tolerant older users (rather than younger users), most overdoses occur in the presence of 
others, most overdoses involve polypharmacy, drug purity has only a moderate influence on 
overdose rates, and most deaths appear to involve relatively low morphine concentrations [7, 
8]. 
 
In recent years, responses to heroin overdoses have included training both drug users and 
their family members in resuscitation techniques [9-11]. Authors have also recommended that 
overdose prevention strategies should promote behavioural changes by heroin users (such as 
not mixing opiates and other depressant drugs) [12] and encourage a ‘mutual duty of care’ 
amongst drug users so that they appropriately identify and respond to problems [6]. 
Paramedics and hospital staff have, meanwhile, successfully used the opioid antagonist, 
naloxone, to reverse the effects of heroin overdose [13-15], and, latterly, naloxone access has 
been extended to drug users, their family members and others who might be present at an 
overdose incident [10, 16-21].   
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The likely success of any intervention at the point of overdose depends crucially on the time 
available to act [22]. There is a clinical view that there are two types of overdose: 
‘catastrophic sudden loss of consciousness’ and ‘insidious slow-onset’ [23]. However, 
research evidence suggests that instant deaths are rare and protracted deaths are more 
common [8, 22, 24-27]. According to one review, most individuals die between one and three 
hours after injection [14], whereas scrutiny of witness and police statements, alongside police 
photographs of corpses in situ, has indicated that deaths mostly occur one to two hours after 
the last heroin use [28]. This time lapse creates opportunity for drug-using peers, bystanders 
or first responders to intervene. Nonetheless, witness responses to overdose tend to be poor 
since those present often fear police involvement, may be intoxicated, or can fail to recognise 
the signs of acute respiratory distress [8, 19, 29-31]. 
 
Despite this important body of literature, subjective experiences of overdosing remain 
difficult to interpret, particularly given the lack of qualitative research. Specificially how do 
individuals feel between the point of drug consumption and loss of consciousness, are they 
aware that they are overdosing, and could – indeed would - they act to save themselves? We 
draw upon opiate users’ self-reported accounts of the period immediately preceding a non-
fatal overdose incident in order to i. construct a proto-typology of non-fatal opiate overdose 
onset and ii. assess the implications for overdose management and the prevention of fatalities.  
 
 
METHODS 
 
We have re-analysed data from a qualitative study of non-fatal illicit drug overdose that took 
place over a 13-month period (1997-1998). In the original study, JN conducted in-depth 
interviews with 200 opiate users recruited from five hospitals, eleven drug services and ten 
pharmacies in Glasgow and Dundee, Scotland. The interviews were all 20-90 minutes long, 
audio recorded and transcribed verbatim at the time of the study. Information on ethical 
approval, recruitment procedures, and participant characteristics have been reported 
previously [32-35].  
  
For this report, all interview transcriptions and study fieldnotes were reviewed to identify 
those interviews that had taken place within 24 hours of an overdose event occurring. In total, 
51 interviews fitted the criteria and were isolated for further in-depth analyses. The 24-hour 
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time frame was chosen to maximize participant recall of events and to minimize the 
likelihood of other factors influencing recall accuracy.  
 
The 51 interviews were conducted with 35 men and 16 women; age 16-47 years (mean = 28 
years). Although 35 of the 51 participants had experienced more than one overdose over their 
lifetimes, details of only the most recent (last 24 hours) overdose experienced are analysed 
here. The 51 overdoses had involved a range of prescribed and illicit substances (injected and 
not injected); however, all had involved at least one opioid substance. Forty-eight interviews 
had been conducted in an emergency department, hospital ward or waiting room, and 3 had 
been conducted in the community shortly after hospital discharge. Most participants had been 
treated with naloxone, although the exact number could not be confirmed as the researcher 
did not have access to patient medical records and participants often did not know what 
treatment they had received.  
 
JB read all 51 interview transcriptions and made detailed notes of what had happened in the 
hours and minutes preceding the most recent overdose. These notes were collectively 
reviewed by the team who identified six ‘features of overdose’ for further in-depth scrutiny: i. 
substances used; ii. mode of substance use; iii. where the overdose had occurred; iv. who 
else, if anyone, had been present; v. events leading up to the overdose; and vi. description of 
the overdose event. The six features were entered as column headings into an Excel 
spreadsheet, where each row of the spreadsheet represented one of the 51 overdoses. 
Columns for basic demographic characteristics were also added.  
 
JB next re-read all of the interview transcriptions line-by-line, summarizing the content of 
each interview under the appropriate heading, so that all cells in the spreadsheet were 
populated with text. Once the matrix was complete, similarities and differences between the 
overdose events were explored by reading the spreadsheet both vertically and horizontally. 
This process indicated that column ‘vi. description of the overdose event’ was most central to 
the analysis, but it needed further refinement. Accordingly, three new sub-columns were 
added:  ‘vi-a. memory of the moment of overdose’; ‘vi-b. time to loss of consciousness; and 
‘vi-c. subjective description of the overdose experience’.  
 
JB populated the new cells (n=153 [51 x 3]) with text from the parent cell ‘vi. description of 
the overdose event’. At this point, seven overdose events were deleted due to incomplete 
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data. This left 44 overdoses for the analyses. The content of the remaining cells (n=132 [44 x 
3]) was next compared, contrasted and grouped using a systematic and iterative process, 
Iterative Categorisation [36]. This generated four basic types of overdose onset. Findings 
were then supplemented by data from the other matrix cells.  
 
 
FINDINGS 
 
 
Proto-typology overview 
 
The four types of overdose onset – with descriptive labels – are presented in Table 1 and 
described in more detail below. No clear differences between the onset of overdoses 
experienced by men (n=30) and women (n=14) or participants of different ages were 
identified.  
 
INSERT TABLE 1  
 
 
Type A onset: “Amnesic” (8 overdoses) 
 
The eight participants describing Type A overdose onset were aged 23-29 years, and just over 
half (n=5) had used heroin intraveneously. Participants all reported rapid, but not immediate, 
loss of consciousness. They had good recall of events leading up to their last drug 
consumption, and remembered some situational information about the overdose. For 
example, six reported that they had been using drugs alone (although one had had her eight-
year-old daughter with her) and two reported using with friends. Three had overdosed 
outside, one in a public toilet, one in a hostel, one in a psychiatric hospital, one in a café, and 
one in a taxi. Despite this, none of the eight participants had any memory of the actual 
moment of overdose and none could describe how they had felt as they lost consciousness 
(see Table 2 for illustrative examples). 
 
INSERT TABLE 2  
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Type B onset: “Conscious” (17 overdoses) 
 
Seventeen participants described Type B overdose onset. They were aged 16-33 years, and 
over half (n=11) had used heroin intravenously. All participants described being conscious as 
the overdose occurred and remaining conscious for some time afterwards (one even drove 
himself to the hospital and another called a taxi). Participants remembered events leading up 
to the overdose. Some reported that they had been using drugs alone (although sometimes 
non-using friends or relatives had been nearby), some said that they had been using with 
friends, and some described using with friends but then overdosing alone later. Four said that 
they had overdosed at home or in ‘a house’, whilst others described a range of overdose 
locations including on the street, in a shopping centre, in a park, at a train station, and in a 
public toilet.  
 
All participants were able to describe the experience of overdosing, explaining that they had 
felt unwell and had known that something was ‘wrong’. Reported symptoms included: 
staggering, drowsiness, sickness, dizziness, numbness, pins and needles, breathlessness, 
hallucinations, palpitations, headache, feeling faint, shaking, headache and fitting (see Table 
3).  
 
INSERT TABLE 3  
 
 
Type C onset: “Instant” (14 overdoses) 
 
This type of overdose onset was described by 14 participants, aged 22-47 years; all had 
injected heroin. Most remembered where they had been and who had been with them prior to 
injecting. Some reported that they had been using drugs alone, some said that they had been 
using drugs with friends, some explained that they had used some of their drugs alone and 
some with friends, and some described how they had been using drugs alone but other people 
(non-drug-using partners, friends, relatives) had been nearby (for example, in another room in 
the same house). Nine said they had overdosed in a house (their own home, a partner’s home 
or a relative’s home) and two said they had overdosed outside; others had no memory of the 
overdose location. Although all participants were able to recall events up to the moment of 
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overdose, they all then described a sudden and abrupt loss of consciousness with no 
recollection of how they had felt or what had happened next (see Table 4).  
 
INSERT TABLE 4  
 
 
Type D onset: “Enjoyable” (5 overdoses) 
 
The 5 participants describing a Type D overdose onset were aged 22-33 years, and nearly all 
(n=4) had used heroin intravenously. All 5 participants were able to provide information 
about where they had been and who had been with them when the overdose had occurred. 
One had used drugs with a friend but overdosed at home alone later. The others had been 
using drugs with friends or partners when they had overdosed. Four had been at home or in a 
house and one in public toilets.  
 
All participants reported losing consciousness rapidly, yet all explained that they had realized 
that they were overdosing. Moreover, unlike participants who described other types of 
overdose onset, these individuals did not refer to the incident in negative terms. Thus, they 
did not report feeling unwell or worried. Instead, they described overdosing as a ‘pleasant’, 
‘great’ or even ‘beautiful’ experience (see Table 5). 
 
INSERT TABLE 5  
 
 
DISCUSSION 
 
Our anlyses have generated a four-fold proto-typology of opiate overdose onset. This 
provides a more nuanced understanding of the time available to act compared with the 
existing clinical and research literature, where overdoses have tended to be polarized into 
either ‘instantaneous’ and ‘catastrophic’ or ‘insidious’ and ‘protracted’ [22, 23]. 
Significantly, our typology also broadens current conceptualizations of opiate overdose onset 
beyond a simple focus on ‘speed of onset’, to include both ‘memory of the moment of 
overdose’ and ‘subjective experience’. 
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A slow onset overdose (Type B) offers more time for others to intervene than does an 
immediate onset overdose (Type C). On the other hand, where an individual suddenly and 
unexpectedly loses consciousness (Type C), ‘shocked’ onlookers may react more proactively 
(so saving life) than in less dramatic (Type B) situations where a victim slowly and perhaps 
imperceptibly stops breathing. Other drug users, as well as non-drug-using others (family, 
friends and professionals) may well be present in the vicinity (even if not at the actual 
overdose scene) and overdoses occur in a wide range of public and private settings (including 
locations visited some time after drugs were consumed). This confirms the importance of 
involving a wide range of individuals in overdose prevention and response training and 
reinforces the need for a ‘mutual duty of care’ amongst drug users themselves [12]. 
 
The identification of different ‘types’ of opiate overdose onset has real practical implications 
for the feasibility and worth of some of the peer-implemented overdose reversal strategies 
recently developed and being applied, such as training in emergency overdose management 
and lay administration of emergency naloxone. Firstly, because time is short, the actions of 
peers and family members may be most critical to saving life in cases of overdoses of sudden 
or rapid onset, especially as the overdose victims are themselves unlikely to be able to initiate 
any emergency call or self-resuscitative action. This applies particularly to overdoses which 
are ‘Instant’ (Type C) and to those where the effects are perceived as ‘Enjoyable’ (Type D).  
 
Secondly, time may be less critical in responding to overdoses which are ‘Conscious’ (Type 
B), where the opiate user may be aware that something is wrong and that some remedial 
action is necessary. However, the challenge here, and also to some extent with ‘Amnesic’ 
(Type A) overdoses, is one of recognition that an emergency situation is developing. The less 
dramatic onset of the overdose may more easily be overlooked and peers may leave such an 
individual to ‘sleep it off’ without realizing the life-threatening and potentially fatal nature of 
the events that are unfolding.  
 
Thirdly, our analyses have implications for an aspect of overdose management that has not 
been well-considered to-date – the ability of the victim to help and treat themselves. Where 
victims retain consciousness for a sustained period and are able to recognize the signs and 
symptoms of an overdose (Type B), they have greatest potential to summon help or even self-
administer naloxone. The near-ubiquity of mobile phones and the advent of both pre-filled, 
ready-to-inject naloxone syringes and nasal spray preparations of naloxone make this 
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increasingly feasible. Training in recognition of the subjective experiences and symptoms of 
overdose onset, as reported by our participants, could potentially increase life-saving 
reactions. Where victims lose consciousness immediately (Type C) or rapidly (Type A), 
calling others for help or the self-administration of an antagonist drug is not likely to occur. 
Where victims recognise that the overdose is occurring but experience it as enjoyable before 
they lose consciousness (Type D), they are again less likely to self-manage the incident 
unless we can develop interventions that help them to recognize (via cognition or autonomic 
reaction) that those pleasurable experiences are dangerous.  
 
Some limitations should be noted. Our findings are based on a small number of overdose 
events occurring nearly twenty years ago in two Scottish cities. We did not employ any 
objective definition of ‘overdose’, seven overdoses could not be analysed because of missing 
data, and we recognise that fatal and non-fatal overdoses are not one and the same 
phenomenon. However, particular strengths of our data and analyses include the successful 
conduct of interviews so proximal to the time of overdose events, no other study has to our 
knowledge reported on this topic, and the fact that participants’ gender and age profile was 
broadly similar to that reported in other national and international studies of drug overdose at 
the time [29, 37, 38].  
 
Caution should, of course, be taken in generalizing from our data to other locations and time 
periods. Although we have reported the number of each overdose type within our sample to 
increase clarity and transparency, no inferences about prevalence can be drawn from these 
data [39]. Indeed, we have deliberately called our findings a ‘proto-typology’ to indicate that 
further research is now needed to test, refine and develop our categorisations. For example, it 
is possible that Type A onset is in practice either Type B or C onset; it is simply that 
intensive drug use has resulted in poor recall (via retrograde or anterograde amnesia). Despite 
these shortcomings, our early framework for identifying different types of overdose onset 
highlights the complexity of overdose events, the need for a range of interventions, and the 
challenges faced in managing incidents and preventing fatalities. Additionally, the 
identification of Type B onset indicates that some opiate overdose victims can potentially 
summon help or self-administer naloxone; consequently, self-management strategies should 
be incorporated into opiate overdose training. 
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TABLES 
 
Table 1: Overdose onset proto-typology 
 
Overdose Type Overdose Features Substances Taken (Number of 
Participants) 
Number of Participants 
Males Females Total 
A. ‘Amnesic’  No memory of the moment of 
overdose 
 Rapid loss of consciousness  
 No description of the overdose 
experience 
 IV heroin only (n=1) 
 IV heroin plus other substances (n=4) 
 Oral opiates plus other substances (n=3) 
5 3 8 
B. ‘Conscious’ 
 
 
 Some memory of the moment of 
overdose 
 A period of consciousness 
maintained  
 Good description of the overdose 
experience (feeling unwell and 
symptomatic) 
 IV heroin only (n=3) 
 IV heroin plus other substances (n=8) 
 Oral opiates plus other substances (n=6) 
10 7 17 
C. ‘Instant’  Some memory of the moment of 
overdose  
 Immediate loss of consciousness  
 No description of the overdose 
experience  
 IV heroin only (n=5) 
 IV heroin plus other substances (n=9) 
 Oral opiates plus other substances (n=0) 
11 3 14 
D. ‘Enjoyable’  
 
 
 Some memory of the moment of 
overdose 
 Rapid loss of consciousness  
 Limited description of the 
overdose experience (not 
unpleasant/ positive) 
 IV heroin only (n=1) 
 IV heroin plus other substances (n=3) 
 Oral opiates plus other substances (n=1) 
4 1 5 
Total   30 14 44 
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Table 2: “Amnesic” - Examples 
 
Details from the interview data and fieldnotes Quotation 
Alan (23 years) reported that he had recently reduced his 
heroin consumption. On the day of the overdose he had 
been told to leave the hostel where he had been staying 
because he had taken drugs and was intoxicated. He said 
that he had felt ‘low’ and did not care whether he lived or 
died. He had then taken more heroin and was wandering 
around outside, but could not remember overdosing. He 
was found unconscious in the street by two non-drug-
using friends who had taken him to the hospital in their 
car.   
“I went and got more heroin. Took more heroin… Then I 
was walking about the street… That’s all I can 
remember.”  
Claire (28 years) was an inpatient in a psychiatric hospital. 
On the day of the overdose, she had taken her prescribed 
medication (benzodiazepines and haloperidol). Her 
partner had then visited and brought her a syringe 
containing heroin. She remembered injecting the heroin in 
the toilets after he left, but nothing after that. Staff from 
the psychiatric ward had found her later in the patients’ 
day room (not the toilets), called an ambulance and took 
her to the hospital. 
“I don’t remember. I remember going in the toilet… I took 
it [heroin] in the toilets.”  
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Table 3: “Conscious” - Examples 
 
Details from the interview data and fieldnotes Quotation 
Louise (26 years) reported that she had not taken her 
prescribed methadone for the last two days, but had used 
heroin and temazepam with her boyfriend the day prior to 
the overdose and amitriptyline alone on the morning of the 
overdose. She had ‘blacked out’ later at midday on her 
way to visit her mother. She described feeling ‘as if in a 
dream’ and remembered repeatedly falling over and 
banging her head, although she could not remember 
anything after that. Two policemen had taken her to the 
emergency department, but Louise had no recollection of 
that. She remarked that this overdose had been different 
from her previous two drug overdoses which had felt 
‘nice’.   
“Jellies [benzodiazepines] first, kit [heroin] next, the 
amitriptyline’s next… I kept falling down [on] the floor 
and banging my head.” 
Nigel (29 years) reported that he usually injected heroin 
intramuscularly because of vein damage. On the day of the 
overdose, he had drunk alcohol and taken temazepam. 
Then someone had injected him intravenously. He 
remembered feeling as though he was about to ‘keel over’ 
and said he knew that the overdose was about to happen as 
he had felt tingling (‘pins and needles’) in his head. He 
explained that he had overdosed many times previously 
and had always felt it ‘coming on’, but the feeling was not 
something that could be controlled. 
“I felt I’m going to keel over. I could feel it… pins and 
needles in my head.” 
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Table 4: “Instant” - Examples 
 
Details from the interview data and fieldnotes Quotation 
Howard (29 years) had been released from prison the day 
before his overdose. He reported that he had been suffering 
from insomnia for a while. On the day of the overdose, he 
had been drinking alcohol. That evening one of his friends 
had injected him with heroin and temazepam. He 
remembered the injection being administered but then 
nothing until he had woken up in the ambulance. 
“I had some heroin and an egg [benzodiazepine]… All I 
remember is something going in my arm…..and that was 
it.”   
James (38 years) reported that he had been drinking 
alcohol prior to injecting heroin. He said that this was only 
the second time he had used heroin and his friend had 
injected him. He stated that he could not remember 
anything about the effects of the heroin as he had instantly 
‘blacked out’ as the needle ‘went in’. 
“It [needle] went in and the lights went out.” 
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Table 5: “Enjoyable” - Examples 
 
Details from the interview data and fieldnotes Quotation 
Hugh (29 years) had recently been released from prison. 
He was at home with his wife and a friend when he had 
injected heroin and overdosed. He had overdosed 
previously and reported that it had always felt similar – 
like ‘going into a lovely sleep’ or ‘being in love’. There 
was no pain, but he had felt ‘groggy’, ‘headachy’ and 
‘stiff’ when he had regained consciousness. He stated that 
he had known he was overdosing but could not stop it from 
happening. He remembered waking up whilst the 
paramedics were taking him from the house into the 
ambulance but then could not remember the rest of the 
journey to the hospital.  
“You know you’re going over [overdosing]… just like a 
beautiful feeling taking over you.” 
Robert (31 years) had been drinking alcohol the evening 
prior to, and on the morning of, the overdose. He had 
stayed up all night drinking with his friend. He said he was 
a heavy drinker and used cannabis regularly but did not 
generally take other drugs. This was only the second time 
he had used heroin, which he had snorted. He remembered 
feeling ‘great’ and then nothing else until he woke up in 
hospital. 
“I felt great, you know. And the next thing, I’ve woke up 
here [in hospital].” 
 
 
